August 11, 2026 — RNews

#pancreatic cancer — Tuesday, August 11, 2026 (1 items)

hot top new

← prev day next day →

0

Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategies in pancreatic cancer. (nature.com)

Aronchik I … Singh M Nature Medicine 2026-08-11

#amr #pancreatic cancer #targeted therapy #kras #circulating tumor dna